MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Distinct roles of PARK2, PINK1, and LRRK2 in neuroinflammation: resistance and susceptibility in immune-mediated mouse models

D. Cossu, H. Okada, S. Noda, Y. Tomizawa, S. Ueno, L. Sechi, T. Hatano, N. Hattori (Tokyo, Japan)

Meeting: 2025 International Congress

Keywords: Inflammation, Leucine-rich repeat kinase 2(LRRK2), PTEN induced kinase-1(PINK1)

Category: Parkinson's Disease: Pathophysiology / molecular mechanisms of disease

Objective: To investigate the impact of PARK2, PINK1, and LRRK2 deficiency on neuroinflammation in aging, using immune-mediated mouse models.

Background: Emerging evidence links mitophagy-related genes, including PARK2 (PARKIN), PINK1, and LRRK2, to immune dysregulation in Parkinson’s disease (PD) and other neurodegenerative disorders. However, their role in age-related neuroinflammation remains unclear.

Method: We evaluated the effects of PARK2, PINK1, and LRRK2 deficiency in neuroinflammation using two models: myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE) to assess immune-driven neurodegeneration, and lipopolysaccharide (LPS) administration to evaluate systemic inflammatory responses.

Results: PARK2 and PINK1 knockout mice (middle-aged and aged) developed more severe EAE, with incomplete recovery, increased monocyte, dendritic cell, and CD8⁺ T-cell responses, along with microglial activation and CNS immune infiltration. LRRK2 knockout mice were completely resistant to EAE, showing impaired thymic selection, homeostatic proliferation, regulatory T cell function, and dendritic cell maturation. LPS administration led to macrophage and plasma cell infiltration in the intestine, along with increased mitotic activity of crypt epithelial cells and epithelial dysplasia in knockout mice.

Conclusion: These findings highlight distinct roles of mitophagy-related genes in neuroinflammation. LRRK2-associated pathways may play a crucial role in modulating immune responses, with potential implications for PD pathogenesis and therapeutic targeting.

References: Cossu D, Hatano T, Hattori N. The Role of Immune Dysfunction in Parkinson’s Disease Development. Int J Mol Sci. 2023 Nov 26;24(23):16766. doi: 10.3390/ijms242316766.
Cossu D, Yokoyama K, Sato S, Noda S, Sakanishi T, Sechi LA, Hattori N. Age related immune modulation of experimental autoimmune encephalomyelitis in PINK1 knockout mice. Front Immunol. 2022 Nov 17;13:1036680. doi: 10.3389/fimmu.2022.1036680.
Cossu D, Yokoyama K, Sato S, Noda S, Sechi LA, Hattori N. PARKIN modifies peripheral immune response and increases neuroinflammation in active experimental autoimmune encephalomyelitis (EAE). J Neuroimmunol. 2021 Oct 15;359:577694. doi: 10.1016/j.jneuroim.2021.577694.

To cite this abstract in AMA style:

D. Cossu, H. Okada, S. Noda, Y. Tomizawa, S. Ueno, L. Sechi, T. Hatano, N. Hattori. Distinct roles of PARK2, PINK1, and LRRK2 in neuroinflammation: resistance and susceptibility in immune-mediated mouse models [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/distinct-roles-of-park2-pink1-and-lrrk2-in-neuroinflammation-resistance-and-susceptibility-in-immune-mediated-mouse-models/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/distinct-roles-of-park2-pink1-and-lrrk2-in-neuroinflammation-resistance-and-susceptibility-in-immune-mediated-mouse-models/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley